Business · 04/11/2019Updated: 10/17/2026 · 1 min read
FDA Announces Public Meeting of Cardiovascular and Renal Drugs Advisory Committee
Summary
The FDA is hosting a public meeting of the Cardiovascular and Renal Drugs Advisory Committee to gather input on regulatory issues, and is seeking public comments on the matter, with the meeting to be held in the near future.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →